University of Arizona launches rapamycin clinical trial with philanthropic support of alumnus Ken Coit (opens in new tab)

Researchers at the University of Arizona R. Ken Coit College of Pharmacy will begin a double-blind, randomized Phase 3 clinical trial this year to evaluate whether a drug used to prevent organ transplant rejection can also improve older adults' resilience and immune function.